Skip to main content
. 2015 Jun 29;9:3361–3368. doi: 10.2147/DDDT.S86344

Table 1.

Initial clinical characteristics of patients

Variable, n (%) Group 1: patients given atorvastatin 20 mg/day (n=110) Group 2: patients given atorvastatin 40 mg/day (n=100) P-value
Men 110 (100) 100 (100)
Age (years) 60.4 (59.5, 61.1) 61.3 (60.9, 64.5) 0.877
Risk factors
Arterial hypertension 80 (72.7) 86 (86) 0.795
Current smoking 70 (63.7) 68 (68) 0.925
Family history of ischemic heart disease 45 (40.9) 50 (50) 0.826
Clinical angina to myocardial infarction 50 (45.5) 55 (55) 0.918
Previous myocardial infarction 20 (18.2) 14 (14) 0.858
History of cerebrovascular accident/transient ischemic attack 5 (4.5) 5 (5) 1.0
Depth of lesion
Q-wave myocardial infarction 80 (72.7) 77 (77) 0.929
Non-Q-wave myocardial infarction 30 (27.3) 25 (25) 0.885
Localization of myocardial infarction
Posterior 60 (54.5) 50 (50) 0.918
Posterior with capture of the right ventricle 20 (18.2) 15 (15) 0.858
Front 30 (27.3) 32 (32) 0.894
Acute heart failure
Killip I 90 (81.8) 86 (86) 0.932
Killip II 10 (9.1) 5 (5) 0.786
Killip III 5 (4.6) 9 (9) 0.786
Killip IV 0 0 1.0

Note: P-value for significant difference between Groups 1 and 2 was <0.05.